Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lumbosacral Radiculopathy: early-phase trial registry
1 of 4 indexed Lumbosacral Radiculopathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Lumbosacral Radiculopathy: 4 US clinical trials tracked, 1 recruiting.
Lumbosacral Radiculopathy is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Eliem Therapeutics (UK), running 1 of these trials.
Enrollment posture brief
Registry condition lumbosacral-radiculopathy
OPEN 1 | RECR 25% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Lumbosacral Radiculopathy lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lumbosacral Radiculopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lumbosacral Radiculopathy is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
National University of Natural Medicine
NCT07125027
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
Kolon Life Science
NCT05613569
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
Eliem Therapeutics (UK)
NCT04778592
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
Medtronic Spinal and Biologics
NCT01917825
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Lumbosacral Radiculopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lumbosacral Radiculopathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lumbosacral Radiculopathy page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Lumbosacral Radiculopathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eliem Therapeutics (UK) sponsors the most Lumbosacral Radiculopathy trials on record, review their full trial history before evaluating a specific study. See Eliem Therapeutics (UK)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lumbosacral Radiculopathy condition card totals 4 registered trials; most-linked intervention MDT-15; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.